Effects of the sodium-glucose cotransporter 2 inhibitor empagliflozin on vascular function in patients with chronic heart failure.

Julie Kolwelter,Agnes Bosch,Susanne Jung, Lena Stabel,Dennis Kannenkeril,Christian Ott,Peter Bramlage,Mario Schiffer,Stephan Achenbach,Roland E Schmieder

ESC heart failure（2021）

引用 13|浏览13

暂无评分

摘要

We found an improvement of vascular function after treatment with empagliflozin that indicates decreased afterload of the left ventricle and may contribute to the beneficial effects of SGLT2 inhibition in HF.

查看译文

关键词

Blood pressure,Central haemodynamics,Chronic heart failure,Empagliflozin,SGLT2 inhibitor,Vascular function

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要